Catalio Capital Management, LP Portfolio Holdings
Catalio Capital Management, LP
- $477 Billion
- Q2 2025
Catalio Capital Management, LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $477 Billion distributed in 40 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $42B, Bridge Bio Pharma, Inc. with a value of $40.1B, Soleno Therapeutics Inc with a value of $34.3B, Ascendis Pharma A/S with a value of $31.1B, and Intuitive Surgical Inc with a value of $30.8B.
Examining the 13F form we can see an increase of $65.8B in the current position value, from $411B to 477B.
Catalio Capital Management, LP is based out at New York, NY
Below you can find more details about Catalio Capital Management, LP portfolio as well as his latest detailed transactions.